Lilly 8 november 2023 Na GLP-1 nu ook tweede GLP-1/GIP goedgekeurd in Verenigde Staten Er lijkt concurrentie voor de Deense farmaceut Novo Nordisk aan te komen op de markt voor therapien voor chronisch gewichtsmanagement
For many people struggling with their metabolic health, this reaction isnt working properly, which can lead to blood sugar issues, says Silvana Obici, MD, chief of the division of endocrinology at Stony Brook Medicine and medical director of the Stony Brook University Hospital Diabetes Center in Center Moriches and Lake Grove, New York
AG Wilson encouraged reporting of deceptive sales practices regarding unapproved or compounded weight loss medications
For you as someone considering or using these medications, the practical takeaway is straightforward
The outcome of interest was pancreatitis, which was searched using preferred term (pt) pancreatitis
J Nutr 2010